An increasing number of reports have demonstrated that the NOTCH pathway was required for CD8+ T-cell activation and homeostasis; it is therefore probable that the alteration of this pathway could be useful in guiding the treatment decisions of ESCC when the immune system is involved. The gene discussed is CD8A; the disease is esophageal squamous cell carcinoma.